A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine

Selena Y. Lin, Veerpal Dhillon, Surbhi Jain, Ting-Tsung Chang, Chi Tan Hu, Yih-Jyh Lin, Shun-hua Chen, Kung-Chao Chang, Wei Song, Lixin Yu, Timothy M. Block, Ying Hsiu Su

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) has a 5-year survival rate of <10% because it is difficult to diagnose early. Mutations in the TP53 gene are associated with approximately 50% of human cancers. A hotspot mutation, a G:C to T:A transversion at codon 249 (249T), may be a potential DNA marker for HCC screening because of its exclusive presence in HCC and its detection in the circulation of some patients with HCC. A locked nucleic acid clamp-mediated PCR assay, followed by melting curve analysis (using the SimpleProbe), was developed to detect the TP53 249T mutation. In this assay, the locked nucleic acid clamp suppressed 107 copies of wild-type templates and permitted detection of 249Tmutated template, with a sensitivity of 0.1% (1:1000) of the mutant/wild-type ratio, assessed by a reconstituted standard within 2 hours. With an amplicon size of 41 bp, it detects target DNA sequences in short fragmented DNA templates. The detected mutations were validated by DNA sequencing analysis. We then tested DNA isolated from urine samples of patients with HCC for p53 mutations and identified positive TP53 mutations in 9 of 17 samples. The possibility of using this novel TP53 249T assay to develop a urine or blood test for HCC screening is discussed.

Original languageEnglish
Pages (from-to)474-484
Number of pages11
JournalJournal of Molecular Diagnostics
Volume13
Issue number5
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Codon
Hepatocellular Carcinoma
Urine
Polymerase Chain Reaction
Mutation
DNA
p53 Genes
Hematologic Tests
DNA Sequence Analysis
Genetic Markers
Freezing
locked nucleic acid
Survival Rate
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Medicine

Cite this

Lin, Selena Y. ; Dhillon, Veerpal ; Jain, Surbhi ; Chang, Ting-Tsung ; Hu, Chi Tan ; Lin, Yih-Jyh ; Chen, Shun-hua ; Chang, Kung-Chao ; Song, Wei ; Yu, Lixin ; Block, Timothy M. ; Su, Ying Hsiu. / A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine. In: Journal of Molecular Diagnostics. 2011 ; Vol. 13, No. 5. pp. 474-484.
@article{399f352280604e32baeb57a767c83d2d,
title = "A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine",
abstract = "Hepatocellular carcinoma (HCC) has a 5-year survival rate of <10{\%} because it is difficult to diagnose early. Mutations in the TP53 gene are associated with approximately 50{\%} of human cancers. A hotspot mutation, a G:C to T:A transversion at codon 249 (249T), may be a potential DNA marker for HCC screening because of its exclusive presence in HCC and its detection in the circulation of some patients with HCC. A locked nucleic acid clamp-mediated PCR assay, followed by melting curve analysis (using the SimpleProbe), was developed to detect the TP53 249T mutation. In this assay, the locked nucleic acid clamp suppressed 107 copies of wild-type templates and permitted detection of 249Tmutated template, with a sensitivity of 0.1{\%} (1:1000) of the mutant/wild-type ratio, assessed by a reconstituted standard within 2 hours. With an amplicon size of 41 bp, it detects target DNA sequences in short fragmented DNA templates. The detected mutations were validated by DNA sequencing analysis. We then tested DNA isolated from urine samples of patients with HCC for p53 mutations and identified positive TP53 mutations in 9 of 17 samples. The possibility of using this novel TP53 249T assay to develop a urine or blood test for HCC screening is discussed.",
author = "Lin, {Selena Y.} and Veerpal Dhillon and Surbhi Jain and Ting-Tsung Chang and Hu, {Chi Tan} and Yih-Jyh Lin and Shun-hua Chen and Kung-Chao Chang and Wei Song and Lixin Yu and Block, {Timothy M.} and Su, {Ying Hsiu}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.jmoldx.2011.05.005",
language = "English",
volume = "13",
pages = "474--484",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "5",

}

A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine. / Lin, Selena Y.; Dhillon, Veerpal; Jain, Surbhi; Chang, Ting-Tsung; Hu, Chi Tan; Lin, Yih-Jyh; Chen, Shun-hua; Chang, Kung-Chao; Song, Wei; Yu, Lixin; Block, Timothy M.; Su, Ying Hsiu.

In: Journal of Molecular Diagnostics, Vol. 13, No. 5, 01.01.2011, p. 474-484.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine

AU - Lin, Selena Y.

AU - Dhillon, Veerpal

AU - Jain, Surbhi

AU - Chang, Ting-Tsung

AU - Hu, Chi Tan

AU - Lin, Yih-Jyh

AU - Chen, Shun-hua

AU - Chang, Kung-Chao

AU - Song, Wei

AU - Yu, Lixin

AU - Block, Timothy M.

AU - Su, Ying Hsiu

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Hepatocellular carcinoma (HCC) has a 5-year survival rate of <10% because it is difficult to diagnose early. Mutations in the TP53 gene are associated with approximately 50% of human cancers. A hotspot mutation, a G:C to T:A transversion at codon 249 (249T), may be a potential DNA marker for HCC screening because of its exclusive presence in HCC and its detection in the circulation of some patients with HCC. A locked nucleic acid clamp-mediated PCR assay, followed by melting curve analysis (using the SimpleProbe), was developed to detect the TP53 249T mutation. In this assay, the locked nucleic acid clamp suppressed 107 copies of wild-type templates and permitted detection of 249Tmutated template, with a sensitivity of 0.1% (1:1000) of the mutant/wild-type ratio, assessed by a reconstituted standard within 2 hours. With an amplicon size of 41 bp, it detects target DNA sequences in short fragmented DNA templates. The detected mutations were validated by DNA sequencing analysis. We then tested DNA isolated from urine samples of patients with HCC for p53 mutations and identified positive TP53 mutations in 9 of 17 samples. The possibility of using this novel TP53 249T assay to develop a urine or blood test for HCC screening is discussed.

AB - Hepatocellular carcinoma (HCC) has a 5-year survival rate of <10% because it is difficult to diagnose early. Mutations in the TP53 gene are associated with approximately 50% of human cancers. A hotspot mutation, a G:C to T:A transversion at codon 249 (249T), may be a potential DNA marker for HCC screening because of its exclusive presence in HCC and its detection in the circulation of some patients with HCC. A locked nucleic acid clamp-mediated PCR assay, followed by melting curve analysis (using the SimpleProbe), was developed to detect the TP53 249T mutation. In this assay, the locked nucleic acid clamp suppressed 107 copies of wild-type templates and permitted detection of 249Tmutated template, with a sensitivity of 0.1% (1:1000) of the mutant/wild-type ratio, assessed by a reconstituted standard within 2 hours. With an amplicon size of 41 bp, it detects target DNA sequences in short fragmented DNA templates. The detected mutations were validated by DNA sequencing analysis. We then tested DNA isolated from urine samples of patients with HCC for p53 mutations and identified positive TP53 mutations in 9 of 17 samples. The possibility of using this novel TP53 249T assay to develop a urine or blood test for HCC screening is discussed.

UR - http://www.scopus.com/inward/record.url?scp=82755191709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82755191709&partnerID=8YFLogxK

U2 - 10.1016/j.jmoldx.2011.05.005

DO - 10.1016/j.jmoldx.2011.05.005

M3 - Article

VL - 13

SP - 474

EP - 484

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 5

ER -